Skip to content

Richard A. Heyman, Director at Oric Pharmaceuticals, sold ORIC on Jul 24, 2026

Data as of Oct 16

▼ SELL$73.3K6,100 shares at $12.02Richard A. Heyman DirectorORIC Oric Pharmaceuticals, Inc.
Watch ORIC
Traded
Jul 24, 2026
Disclosed
Jul 28, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Richard A. Heyman, Director at Oric Pharmaceuticals, sold ORIC on Jul 24, 2026TRADEDDISCLOSED
ORICSimilar stocks (S&P 500 (SPY)), rebased to ORIC's price on the disclosure day
ORIC since disclosure
+3.7%
after the sale
Similar stocks (SPY) since disclosure
+3.0%
S&P 500 (SPY)

Change in closing price from Jul 28, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLRichard A. Heyman DirectorORIC Oric Pharmaceuticals, Inc.$84.1Kdisclosed Jul 28 · filed 4 days after the trade

See every trade on ORIC →